Elevation of O-GlcNAc and GFAT expression by nicotine exposure promotes epithelial-mesenchymal transition and invasion in breast cancer cells

Cell Death Dis. 2019 Apr 24;10(5):343. doi: 10.1038/s41419-019-1577-2.

Abstract

Cigarette smoking has been shown to be a carcinogenic factor in breast cancer. Nicotine (Nic), an active component of tobacco, has been found to induce epithelial-mesenchymal transition (EMT) in breast cancer cells. However, the alterations in protein O-GlcNAcylation in Nic-mediated tumorigenesis and malignization mechanisms are less well studied. Herein, we found that cellular O-GlcNAcylation dramatically increased in human breast cancer cells with EMT activation induced by Nic. Elevated O-GlcNAcylation subsequently promoted Nic-induced EMT activation and increased cell migratory abbility. In addition, we demonstrated that a differentiation factor for the mammary epithelium, CCAAT/enhancer-binding protein B (CEBPB), was involved in Nic-induced hyper-O-GlcNAcylation via transcriptional regulation of the expression of the key enzyme glutamine: fructose-6-phosphate amidotransferase (GFAT) and thus increased the flux through the hexosamine biosynthetic pathway (HBP). Finally, elevated O-GlcNAcylation of the transcriptional repressor C/EBP homologous protein (CHOP) suppressed its heterodimerization with CEBPB and facilitated the DNA-binding activity of CEBPB, further generating positive feedback that enhanced EMT upon Nic stimulation. In conclusion, our results have revealed a new regulatory mechanism involving CEBPB/GFAT-induced hyper-O-GlcNAcylation that plays a key role in EMT and smoking-mediated breast cancer progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acylation
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • CCAAT-Enhancer-Binding Protein-beta / metabolism
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Epithelial-Mesenchymal Transition / drug effects*
  • Female
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) / antagonists & inhibitors
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) / genetics
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) / metabolism*
  • Humans
  • N-Acetylglucosaminyltransferases / antagonists & inhibitors
  • N-Acetylglucosaminyltransferases / genetics
  • N-Acetylglucosaminyltransferases / metabolism*
  • Nicotine / pharmacology*
  • Promoter Regions, Genetic
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Transcription Factor CHOP / metabolism

Substances

  • CCAAT-Enhancer-Binding Protein-beta
  • CEBPB protein, human
  • DDIT3 protein, human
  • RNA, Small Interfering
  • Transcription Factor CHOP
  • Nicotine
  • N-Acetylglucosaminyltransferases
  • O-GlcNAc transferase
  • Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)